Edesa Biotech (EDSA) Current Assets (2013 - 2026)
Edesa Biotech (EDSA) posted Current Assets of $10.78 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 15.5% from $12.76 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Current Assets came in at $11.51 million, up 587.1% from FY2024.
- Annual Current Assets shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Current Assets was $1.68 million in FY2024 (-74.0%), $6.44 million in FY2023 (-29.2%), $9.09 million in FY2022 (-24.8%) and $12.09 million in FY2021 (+49.2%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Current Assets since fiscal Q1 2025.
- On a year-over-year basis, Current Assets increased in four of the last seven quarters, with growth averaging 215.4%.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q4 2025, with growth of 587.1%; the weakest was fiscal Q4 2024, with a decline of 74.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 10.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.78 Mn |
| Dec 31, 2025 | 12.72 Mn |
| Sep 30, 2025 | 11.51 Mn |
| Jun 30, 2025 | 12.76 Mn |
| Mar 31, 2025 | 14.39 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Sep 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 6.44 Mn |
| Jun 30, 2023 | 6.91 Mn |
| Mar 31, 2023 | 8.13 Mn |
| Dec 31, 2022 | 9.09 Mn |
| Sep 30, 2022 | 9.09 Mn |
| Jun 30, 2022 | 15.18 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 9.89 Mn |
| Sep 30, 2021 | 12.09 Mn |
| Jun 30, 2021 | 14.33 Mn |
API Access
Edesa Biotech Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();